Arrivent Biopharma Inc (AVBP)

Operating Expenses

$175.94M

TTM · Period ending: · USD

AVBP logo

AVBP Operating Expenses

Latest reported$175.94M
AVBP Operating Expenses ($8.70M → $175.94M)
High-resolution chart · PNG

AVBP operating expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Arrivent Biopharma Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
177,534,000
94,308,000
74,590,000
36,906,000
8,696,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.